| 注册
首页|期刊导航|郑州大学学报(医学版)|血必净注射液治疗重症肺炎的临床疗效和安全性评价

血必净注射液治疗重症肺炎的临床疗效和安全性评价

高延秋 张华 刘敏 周丽娟 孙广信 任英杰

郑州大学学报(医学版)Issue(6):837-840,4.
郑州大学学报(医学版)Issue(6):837-840,4.DOI:10.13705/j.issn.1671-6825.2014.06.019

血必净注射液治疗重症肺炎的临床疗效和安全性评价

Clinical efficacy and safety observation of Xuebijing injection in patients with severe pneumonia

高延秋 1张华 1刘敏 1周丽娟 1孙广信 1任英杰1

作者信息

  • 1. 郑州大学附属郑州中心医院呼吸重症医学科郑州450007
  • 折叠

摘要

Abstract

Aim:To observe the clinical efficacy and safety of Xuebijing injection in patients with severe pneumonia . Methods:A total of 126 patients with severe pneumonia were divided into routine group (n=63)and treatment group(n=63).Patients in the routine group were in routine therapy .Treatment of routine therapy combined with Xuebijing injection was applied in the treatment group .The clinical efficacy in the two groups were observed .Results:The effective rate was higher in treatment group than that of the routine group (87.30% vs 66.67%,χ2 =7.570,P=0.006).The mechanical ventilation time,antibiotic using time, and hospital stay shortened in treatment group (t =7.183,6.102,7.616,P <0.001).The fatality rate at 60th of treatment group was lower compared with that of routine group (7.94% vs 20.63%,χ2 =4.148,P=0.036).There were no obvious adverse reaction in two groups .Conclusion:Treatment of routine therapy combined with Xuebijing injection for severe pneumonia has certain clinical application value .

关键词

血必净注射液/重症肺炎/临床疗效/安全性

Key words

Xuebijing injection/severe pneumonia/clinical efficacy/safety

分类

医药卫生

引用本文复制引用

高延秋,张华,刘敏,周丽娟,孙广信,任英杰..血必净注射液治疗重症肺炎的临床疗效和安全性评价[J].郑州大学学报(医学版),2014,(6):837-840,4.

基金项目

郑州市中原区科技攻关计划项目中原科[2013]23号 ()

郑州大学学报(医学版)

OA北大核心CSTPCD

1671-6825

访问量0
|
下载量0
段落导航相关论文